Patents by Inventor HYE-SOOK KWON

HYE-SOOK KWON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240115615
    Abstract: Modified stem cells and methods of use for stem cell transplant are provided.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 11, 2024
    Inventors: Wendy PANG, Judith SHIZURU, Robert SIKORSKI, Rajiv TIWARI, Hye-Sook KWON
  • Publication number: 20230233616
    Abstract: The present invention provides clinical evidence for a method of stem cell transplantation that facilitates engraftment and reconstitutes immunocompetence of the recipient without requiring myeloablative conditioning.
    Type: Application
    Filed: March 14, 2023
    Publication date: July 27, 2023
    Inventors: Rajni Agarwal, Janel Long Boyle, Morton J. Cowan, Christopher Dvorak, Hye-Sook Kwon, Anne Le, Aaron Logan, Wendy Pang, Robertson Parkman, Maria-Grazia Roncarolo, Kenneth Weinberg, Judith A. Shizuru, Susan Sweeney Prohaska, Agnieszka Czechowicz, Irving L. Weissman
  • Patent number: 11642379
    Abstract: The present invention provides clinical evidence for a method of stem cell transplantation that facilitates engraftment and reconstitutes immunocompetence of the recipient without requiring myeloablative conditioning.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: May 9, 2023
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California
    Inventors: Rajni Agarwal, Janel Long Boyle, Morton J. Cowan, Christopher Dvorak, Hye Sook Kwon, Anne Le, Aaron Logan, Wendy Pang, Robertson Parkman, Maria-Grazia Roncarolo, Kenneth Weinberg, Judith A. Shizuru, Susan Sweeney Prohaska, Agnieszka Czechowicz, Irving L. Weissman
  • Publication number: 20210369782
    Abstract: The present invention provides clinical evidence for a method of stem cell transplantation that facilitates engraftment and reconstitutes immunocompetence of the recipient without requiring myeloablative conditioning.
    Type: Application
    Filed: December 7, 2018
    Publication date: December 2, 2021
    Inventors: Rajni Agarwal, Janel Long Boyle, Morton J. Cowan, Christopher Dvorak, Hye Sook Kwon, Anne Le, Aaron Logan, Wendy Pang, Robertson Parkman, Maria-Grazia Roncarolo, Kenneth Weinberg, Judith A. Shizuru, Susan Sweeney Prohaska
  • Patent number: 8748464
    Abstract: The present disclosure provides a method of increasing an immune response in an individual, the method involving administering to an individual in need thereof an inhibitor of SIRT1. The present disclosure provides a method of reducing an immune response, e.g., to treat chronic immune hyperactivity, the method generally involving administering to an individual in need thereof an activator of SIRT1. The present disclosure provides a method of modulating activation and differentiation of CD4+ T cells.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: June 10, 2014
    Assignee: The J. David Gladstone Institutes
    Inventors: Eric M. Verdin, Melanie Ott, Hye-Sook Kwon, Hyungwook Lim
  • Publication number: 20100330114
    Abstract: The present disclosure provides a method of increasing an immune response in an individual, the method involving administering to an individual in need thereof an inhibitor of SIRT1. The present disclosure provides a method of reducing an immune response, e.g., to treat chronic immune hyperactivity, the method generally involving administering to an individual in need thereof an activator of SIRT1. The present disclosure provides a method of modulating activation and differentiation of CD4+T cells.
    Type: Application
    Filed: July 16, 2010
    Publication date: December 30, 2010
    Inventors: ERIC M. VERDIN, MELANIE OTT, HYE-SOOK KWON, HYUNGWOOK LIM